As a responsible global development and manufacturing partner, we are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, our partners and customers as well as their patients.
tesa Labtec set up a COVID-19 task force in February, supported by specialists from all departments including health to minimize any potential affect to our supply chain, our production, labs and offices and moreover to protect all tesa Labtec employees in order to ensure continuity in our development activities and product supply.
So far, there is no negative impact to our delivery accuracy expected. If we become aware of any, we will inform you immediately. Vice versa, any information from your side regarding material demand deviations would enable us to calibrate towards a fast response to your inquiry.
Please contact your existing tesa Labtec representative for any question.
Your tesa Labtec Management
See you at the Pharma Contract Manufacturing Conference: NEW: September 3-4, 2020, The Westin Grand Munich, Germany.
Get in contact with Timo, Head of BD & Marketing
NEW DATE: September 9-11 2020.
Match and Meet during CPhI north america 2020.
NEW DATE: October 12-14, 2020
We are looking forward to seeing you there with one-on-one partnering meetings.
tesa Labtec will be exhibiting at CPhI Worldwide in Milan, Italy from October 13-15, Booth 2F130